• Dalton to Start GMP Mfg. for Inhalation Drug Candidate contractpharma
    May 09, 2017
    Dalton Pharma Services has launched the good manufacturing practice (GMP) campaign for Arch Biopartners’ AB569, an inhalation drug candidate for treating antibiotic-resistant bacterial infections in the lungs.
PharmaSources Customer Service